Transcriptional profiling of γδ T cells identifies a role for vitamin D in the immunoregulation of the Vγ9Vδ2 response to phosphate-containing ligands

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6144-6152

  Chen, Lanfen ^a   Cencioni, Maria Teresa ^b   Angelini, Daniela F ^b   Borsellino, Giovanna ^b   Battistini, Luca ^b   Brosnan, Celia F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALKYL GROUP; CALCITRIOL; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; ISOPENTYL PYROPHOSPHATE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATE; PROTEIN KINASE B; PROTEIN KINASE C; ROTTLERIN; STEROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CALCIUM METABOLISM; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATORY DISEASE; NUCLEOTIDE SEQUENCE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 18644369789     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6144     Document Type: Article

References (60)

1. Griffin, M. D., N. Xing, and R. Kumar. 2003. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 23: 117-145.
2. Brown, A. J., A. Dusso, and E. Slatopolsky. 1999. Vitamin D. Am. J. Physiol. 277: F157-F175.
3. Bouillon, R., A. Verstuyf, L. Verlinden, K. Allewaert, D. Branisteanu, C. Mathieu, and H. van Baelen. 1995. Non-hypercalcemic pharmacological aspects of vitamin D analogs. Biochem. Pharmacol. 50: 577-583.
4. Fleet, J. C. 2004. Rapid, membrane-initiated actions of 1,25 dihydroxyvitamin D: what are they and what do they mean? J. Nutr. 134: 3215-3218.
5. DeLuca, H. F. 1992. New concepts of vitamin D functions. Ann. NY Acad. Sci. 669: 59-68.
6. Deluca, H. F., and M. T. Cantorna. 2001. Vitamin D: its role and uses in immunology. FASEB J. 15: 2579-2585.
7. Holick, M. F. 2003. Vitamin D: a millenium perspective. J. Cell. Biochem. 88: 296-307.
8. Bhalla, A. K., E. P. Amento, T. L. Clemens, M. F. Holick, and S. M. Krane. 1983. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57: 1308-1310.
9. Provvedini, D. M., C. D. Tsoukas, L. J. Deftos, and S. C. Manolagas. 1983. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181-1183.
10. Iho, S., T. Takahashi, F. Kura, H. Sugiyama, and T. Hoshino. 1986. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J. Immunol. 136: 4427-4431.
11. 3 receptor in the immune system. Arch. Biochem. Biophys. 374: 334-338.
12. + T cells to enhance the development of Th2 cells. J. Immunol. 167: 4974-4980.
13. + T cells. J. Immunol. 168: 1181-1189.
14. Piemonti, L., P. Monti, M. Sironi, P. Fraticelli, B. E. Leone, E. Dal Cin, P. Allavena, and V. Di Carlo. 2000. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164: 4443-4451.
15. Griffin, M. D., W. Lutz, V. A. Phan, L. A. Bachman, D. J. McKean, and R. Kumar. 2001. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98: 6800-6805.
16. Penna, G., and L. Adorini. 2000. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411.
17. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
18. De Libero, G. 2000. Tissue distribution, antigen specificity and effector functions of γδT cells in human diseases. Springer Semin. Immunopathol. 22: 219-238.
19. Tanaka, Y., C. T. Morita, Y. Tanaka, E. Nieves, M. B. Brenner, and B. R. Bloom. 1995. Natural and synthetic nonpeptide antigens recognised by human γδ T cells. Nature 375: 155-158.
20. Morita, C. T., R. A. Mariuzza, and M. B. Brenner. 2000. Antigen recognition by human γδ T cells: pattern recognition by the adaptive immune system. Springer Semin. Immunopathol. 22: 191-217.
21. Bukowski, J. F., C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner, and H. Band. 1995. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154; 998-1006.
22. Cipriani, B., G. Borsellino, F. Poccia, R. Placido, D. Tramonti, S. Bach, L. Battistini, and C. F. Brosnan. 2000. Activation of C-C β-chemokines in human peripheral blood γδ T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood 95: 39-47.
23. Poccia, F., B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. Lopez-Botet, J. J. Fournie, and M. L. Gougeon. 1997. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes. J. Immunol. 159: 6009-6017.
24. Stinissen, P., C. Vandevyver, R. Medaer, L. Vandegaer, J. Nies, L. Tuyls, D. A. Hafler, J. Raus, and J. Zhang. 1995. Increased frequency of γδ T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis: reactivity, cytotoxicity. and T cell receptor V gene rearrangements. J. Immunol. 154: 4883-4894.
25. Battistini, L., K. Selmaj, C. Kowal, J. Ohmen, R. L. Modlin, C. S. Raine, and C. F. Brosnan. 1995. Multiple sclerosis: limited diversity of the Vδ2-Jδ3 T-cell receptor in chronic active lesions. Ann. Neurol. 37: 198-203.
26. Shimonkevitz, R., C. Colburn, J. A. Burnham, R. S. Murray, and B. L. Kotzin. 1993. Clonal expansions of activated γ/δ T cells in recent-onset multiple sclerosis. Proc. Natl. Acad. Sci. USA 90: 923-927.
27. Nowak, J., D. Januszkiewicz, M. Pernak, H. Hertmanowska, K. Nowicka-Kujawska, J. Rembowska, K. Lewandowski, T. Nowak, and M. Wender. 2001. Limited pattern of TCR δ chain gene rearrangement on the RNA level in multiple sclerosis. J. Appl. Genet. 42: 531-540.
28. Rajan, A. J., Y. L. Gao, C. S. Raine, and C. F. Brosnan. 1996. A pathogenic role for γδ T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse. J. Immunol. 157: 941-949.
29. Rajan, A. J., J. D. Klein, and C. F. Brosnan. 1998. The effect of γδ T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis. J. Immunol. 160: 5955-5962.
30. Spahn, T. W., S. Issazadah, A. J. Salvin, and H. L. Weiner. 1999. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR 5 chain gene. Eur. J. Immunol. 29: 4060-4071.
31. VanAmerongen, B. M., C. D. Dijkstra, P. Lips, and C. H. Polman. 2004. Multiple sclerosis and vitamin D: an update. Eur. J. Clin. Nutr. 58: 1095-1109.
32. Cantorna, M. T., and B. D. Mahon. 2004. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. 229: 1136-1142.
33. Munger, K. L., S. M. Zhang, E. O'Reilly, M. A. Herman, M. J. Oleck, W. C. Willett, and A. Ascherio. 2004. Vitamin D intake and incidence of multiple sclerosis. Neurology 61: 60-65.
34. Cipriani, B., H. Knowles, L. Chen, L. Battistini, and C. F. Brosnan. 2002. Involvement of classical and novel protein kinase C isoforms in the response of human Vγ9Vδ2 T cells to phosphate antigens. J. Immunol. 169: 5761-5770.
35. Miyamoto, K., R. A. Kesterson, H. Yamamoto, Y. Taketani, E. Nishiwaki, S. Tatsumi, Y. Inoue, K. Morita, E. Takeda, and J. W. Pike. 1997. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol. Endocrinol. 11: 1165-1179.
36. Krishnan, A. V., and D. Feldman. 1991. Cyclic adenosine 3′,5′-monophosphate upregulates 1,25-dihydroxyvitamin D receptor gene expression and enhances hormone action. Mol Endocrinol. 6: 198-206.
37. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273: 18623-18632.
38. Christakos, S., P. Dhawan, Y. Liu, X. Peng, and A. J Porta. 2003. New insights into the mechanisms of vitamin D action. J. Cell Biochem. 88: 695-705.
39. van Halteren, A. G., O. M. Tysma, E. van Etten, C. Mathieu, and B. O. Roep. 2004. 1α,25-Dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J. Autoimmun. 23: 233-239.
40. Cipriani, B., G. Borsellino, H. Knowles, D. Tramonti, F. Cavaliere, G. Bernardi, L. Battistini, and C. F. Brosnan. 2001. Curcumin inhibits activation of Vγ9Vδ2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J. Immunol. 167: 3454-3462.
41. Reinhardt, T. A., and R. L. Horst. 1994. Phorbol 12-myristate 13-acetate and 1,25-dihydroxyvitamin D3 regulate 1,25-dihydroxyvitamin D3 receptors synergistically in rat osteosarcoma cells. Mol. Cell. Endocrinol. 101: 159-165.
42. Barletta, F., P. Dhawan, and S. Christakos. 2004. Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription. Am. J. Physiol. 286: E598-E608.
43. 3-induced growth inhibition. J. Biol. Chem. 277: 25884-25892.
44. Koyama, H., M. Inaba, Y. Nishizawa, S. Ohno, and H. Morii. 1994. Protein kinase C is involved in 24-hydroxylase gene expression induced by 1,25(OH)2D3 in rat intestinal epithelial cells. J. Cell. Biochem. 55: 230-240.
45. Krishnan, A. V., and D. Feldman. 1991. Activation of protein kinase-C inhibits vitamin D receptor gene expression. Mol. Endocrinol. 5: 605-612.
46. van Leeuwen, J. P., J. C. Birkenhager, C. J. Buurman, G. J. van den Bemd, M. P. Bos, and H. A. Pols. 1992. Bidirectional regulation of the 1,25-dihydroxyvitamin D3 receptor by phorbol ester-activated protein kinase-C in osteoblast-like cells: interaction with adenosine 3′,5′- monophosphate-induced up-regulation of the 1,25-dihydroxyvitamin D3 receptor. Endocrinology 130: 2259-2266.
47. Reichel, H., H. P. Koeffler, A. Tobler, and A. W. Norman. 1987. 1α,25-Dihydroxyvitamin D3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 84: 3385-3389.
48. Cippitelli, M., and A. Santoni. 1998. Vitamin D3: a transcriptional modulator of the interferon-γ gene. Eur. J. Immunol. 28: 3017-3030.
49. Froicu, M., V. Weaver, T. A. Wynn, M. A. McDowell, J. E. Welsh, and M. T. Cantorna. 2003. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17: 2386-2392.
50. Lemire, J. M., and D. C. Archer. 1991. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87: 1103-1107.
51. Cantorna, M. T., C. E. Hayes, and H. F. DeLuca. 1996. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 93: 7861-7864.
52. 3. Eur. J. Immunol. 30: 498-508.
53. Cantorna, M. T., C. E. Hayes, and H. F. DeLuca. 1998. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr. 128: 68-72.
54. Cantorna, M. T., C. Munsick, C. Bemiss, and B. D. Mahon. 2000. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130: 2648-2652.
55. Nashold, F. E., D. J. Miller, and C. E. Hayes. 2000. 1,25- Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 103: 171-179.
56. 3 prevention of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 119: 16-29.
57. Spach, K. M., L. B. Pedersen, F. E. Nashold, T. Kayo, B. S. Yandell, T. A. Prolla, and C. E. Hayes. 2004. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol. Genomics. 18: 141-151.
58. Cippitelli, M., C. Fionda, D. Di Bona, F. Di Rosa, A. Lupo, M. Piccoli, L. Frati, and A Santoni. 2002 Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes. J. Immunol. 168: 1154-1166.
59. Angelini, D. F., G. Borsellino, M. Poupot, A. Diamantini, R. Poupot, G. Bernardi, F. Poccia, J. J. Fournie, and L. Battistini. 2004. FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways. Blood 104: 1801-1807.
60. Wang, T. T., F. P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J. H. Hanrahan, et al. 2004. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173: 2909-2912.